Immunology News and Research

Latest Immunology News and Research

Sharp rise recorded in cases of new strain of whooping cough: New genotype may be evading vaccine’s protective effects

Australia’s prolonged whooping cough epidemic has entered a disturbing new phase, with a study showing a new strain or genotype may be responsible for the sharp rise in the number of cases.

20 Mar 2012

AAFA releases new 'Spring Allergy Capital' rankings

Today is the vernal equinox – otherwise known as the official end of winter and the start of spring. But even if you didn't look at your calendar today, chances are your nose already figured it out. That's because more than 40 million Americans have nasal allergies.

20 Mar 2012

New information on efficacy of CLA in treating Crohn's disease

The Nutritional Immunology and Molecular Medicine Laboratory (NIMML) research team at Virginia Tech has discovered important new information on the efficacy of conjugated linoleic acid (CLA) in treating Crohn's disease, a form of inflammatory bowel disease (IBD). CLA is a naturally occurring acid found in meat and dairy products known for its anti-cancer and immune modulatory properties.

20 Mar 2012

Boston Scientific lauds private insurance reimbursement coverage for bronchial thermoplasty

Boston Scientific Corporation welcomes a milestone in private insurance reimbursement coverage for bronchial thermoplasty (BT) performed using the Alair Bronchial Thermoplasty System. Minnesota-based HealthPartners and Michigan-based Priority Health recently issued the first public postings of positive insurance coverage policies providing their respective memberships with reimbursement for this novel procedure to treat severe asthma.

19 Mar 2012

arGEN-X introduces NHance technology to create therapeutic antibodies

arGEN-X announces today the launch of NHance, its latest cutting-edge technology enabling the creation of truly differentiated human antibody therapeutics.

19 Mar 2012

Scientist generates mutant version of IL-2 protein to treat advanced cancers

The utility of a naturally occurring protein given, sometimes to great effect, as a drug to treat advanced cancers is limited by the severe side effects it sometimes causes. But a Stanford University School of Medicine scientist has generated a mutant version of the protein whose modified shape renders it substantially more potent than the natural protein while reducing its toxicity.

19 Mar 2012

BC BS of Florida retires negative medical policy for FeNO testing

Aerocrine AB announces that BlueCross BlueShield (BC BS) of Florida1 has retired/archived their negative medical policy for FeNO testing. The change is effective March 15, 2012.

17 Mar 2012

Antibiotics may increase incidence and severity of allergic asthma in early life

Widely used antibiotics may increase incidence and severity of allergic asthma in early life, according to a University of British Columbia study.

17 Mar 2012

UAB researchers develop new vehicle to release proteins with therapeutic effects

UAB researchers developed a new vehicle to release proteins with therapeutic effects. The vehicles are known as "bacteria inclusion bodies", stable insoluble nanoparticles which are found normally in recombinant bacteria.

17 Mar 2012

Abbott initiates enrollment in two HUMIRA Phase 3 trials for moderate to severe HS

Abbott today announced the initiation of two Phase 3 clinical trials designed to evaluate the safety and efficacy of an investigational use of HUMIRA (adalimumab) in adult patients with moderate to severe hidradenitis suppurativa.

16 Mar 2012

Linking HCV infected people with care is key to reducing related mortality and morbidity

Broader screening to identify people infected with hepatitis C virus (HCV) would likely be cost effective, according to a new report published in Clinical Infectious Diseases.

15 Mar 2012

CUMC scientists develop a way to recreate personalized immune mouse

Columbia University Medical Center (CUMC) scientists have developed a way to recreate an individual's immune system in a mouse. The "personalized immune mouse" offers researchers an unprecedented tool for individualized analysis of abnormalities that contribute to type 1 diabetes and other autoimmune diseases, starting at the onset of disease.

15 Mar 2012

Scientists discover direct biomarker of Chikungunya fever

Recent breakthroughs in Chikungunya research spearheaded by scientists at A*STAR's Singapore Immunology Network (SIgN) have made great strides in the battle against the infectious disease.

15 Mar 2012

Scientists discover cells that chaperone food antigens in the intestine

With every meal, immune cells in the intestine stand like sentries at a citadel, turning away harmful bacteria but allowing vitamins and nutrients to pass. Now, researchers at Washington University School of Medicine in St. Louis have identified the cells that chaperone food antigens, or proteins, in the intestine so that the immune system doesn't mount an attack.

15 Mar 2012

UCSF's School of Pharmacy ranks first and School of Medicine ranks third in nationwide survey

UCSF's School of Pharmacy ranked first in its field this year, while its School of Medicine tied for third place nationwide, according to a new survey conducted by U.S. News & World Report.

14 Mar 2012

Another role for protein Mer in novel, targeted cancer treatments

Since the mid-1990s, doctors have had the protein Mer in their sights - it coats the outside of cancer cells, transmitting signals inside the cells that aid their uncontrolled growth.

14 Mar 2012

FDA panel favors continued research on novel pain medicine

A panel of experts for the U.S. Food and Drugs Administration (FDA) this Monday recommended that the federal government should allow continued testing of an experimental class of pain drugs for arthritis, despite links to bone decay and joint failure.

13 Mar 2012

Inovio achieves strong T cell immune responses in PENNVAX-B Phase I HIV study

Inovio Pharmaceuticals, Inc. announced today that it has achieved strong T cell immune responses in a Phase I clinical study of PENNVAX-B, its product for the treatment of the HIV subtype prevalent in North America and Europe, in HIV-positive subjects.

13 Mar 2012

Trudeau Institute creates TICRO to expand the scope of biomedical research

The Trudeau Institute announced today that it has expanded the scope of its biomedical research by creating a contract research organization (CRO), the Trudeau Institute Contract Research Organization.

13 Mar 2012

Study addresses how human body controls gamma-herpesviruses

New research from the Trudeau Institute addresses how the human body controls gamma-herpesviruses, a class of viruses thought to cause a variety of cancers. The study, carried out in the laboratory of Dr. Marcia Blackman, awaits publication in The Journal of Immunology.

13 Mar 2012

Immunology News and Research

Latest Immunology News and Research

Sharp rise recorded in cases of new strain of whooping cough: New genotype may be evading vaccine’s protective effects

AAFA releases new 'Spring Allergy Capital' rankings

New information on efficacy of CLA in treating Crohn's disease

Boston Scientific lauds private insurance reimbursement coverage for bronchial thermoplasty

arGEN-X introduces NHance technology to create therapeutic antibodies

Scientist generates mutant version of IL-2 protein to treat advanced cancers

BC BS of Florida retires negative medical policy for FeNO testing

Antibiotics may increase incidence and severity of allergic asthma in early life

UAB researchers develop new vehicle to release proteins with therapeutic effects

Abbott initiates enrollment in two HUMIRA Phase 3 trials for moderate to severe HS

Linking HCV infected people with care is key to reducing related mortality and morbidity

CUMC scientists develop a way to recreate personalized immune mouse

Scientists discover direct biomarker of Chikungunya fever

Scientists discover cells that chaperone food antigens in the intestine

UCSF's School of Pharmacy ranks first and School of Medicine ranks third in nationwide survey

Another role for protein Mer in novel, targeted cancer treatments

FDA panel favors continued research on novel pain medicine

Inovio achieves strong T cell immune responses in PENNVAX-B Phase I HIV study

Trudeau Institute creates TICRO to expand the scope of biomedical research

Study addresses how human body controls gamma-herpesviruses

Immunology eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production